A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Accomplishments Bookmark and Share

Accomplishments in Diabetes Research

City of Hope researchers have built the foundation of scientific knowledge upon which the understanding and treatment of diabetes are based.
 
Engineering synthetic insulin

In the late 1970s,  Arthur Riggs , Ph.D., and Keiichi Itakura, Ph.D., produced synthetic human insulin using bacteria. It became the first genetically engineered product approved by the Food and Drug Administration and today is used worldwide by millions of people with diabetes. The breakthrough made insulin more available and affordable and helped launch the biotechnology industry.
City of Hope researchers have made numerous breakthoughs, including in islet-cell transplantation and in the understanding of islet dysfunction.
 
Perfecting islet transplantation protocols

Fouad Kandeel , M.D., Ph.D., perfected clinical islet-cell transplantation protocols and has developed imaging methods that enable physicians to more monitor in real time the health of islets after transplantation.
 
Targeting diabetic complications

Rama Natarajan , Ph.D., and Jerry Nadler, M.D., conducted research dealing with diabetic complications and islet dysfunction. Their work has led to the identification of novel therapeutic targets and agents for the treatment of diabetic complications. Natarajan was also the first to demonstrate the role of epigenetics in diabetic vascular inflammation and in the metabolic memory phenomenon.

Her laboratory was also the first to demonstrate how microRNAs (small, non-coding RNAs) can cause the overproduction of collagen, which creates damage that can lead to kidney abnormalities and renal dysfunction. She used therapeutic interventions to block these microRNAs, slowing the cells’ harmful overproduction of collagen and other proteins and kidney damage.
 
 
Diagnosing type 1 diabetes sooner

Kevin Ferreri , Ph.D., has developed a new method of diagnosing type 1 diabetes. His research team detected unique markings on the DNA of insulin-producing cells. When these cells die during the progression of type 1 diabetes, the markings can be detected on DNA that circulates in the blood. This method can be used to diagnose type 1 diabetes before complications and can be used to test the effectiveness of new treatments.

To read about more of City of Hope researchers’ accomplishments, including the 1940s discovery by Rachmiel Levine, M.D., of insulin’s role in processing sugars, read our Diabetes Program History page. 
 

Accomplishments

Accomplishments in Diabetes Research

City of Hope researchers have built the foundation of scientific knowledge upon which the understanding and treatment of diabetes are based.
 
Engineering synthetic insulin

In the late 1970s,  Arthur Riggs , Ph.D., and Keiichi Itakura, Ph.D., produced synthetic human insulin using bacteria. It became the first genetically engineered product approved by the Food and Drug Administration and today is used worldwide by millions of people with diabetes. The breakthrough made insulin more available and affordable and helped launch the biotechnology industry.
City of Hope researchers have made numerous breakthoughs, including in islet-cell transplantation and in the understanding of islet dysfunction.
 
Perfecting islet transplantation protocols

Fouad Kandeel , M.D., Ph.D., perfected clinical islet-cell transplantation protocols and has developed imaging methods that enable physicians to more monitor in real time the health of islets after transplantation.
 
Targeting diabetic complications

Rama Natarajan , Ph.D., and Jerry Nadler, M.D., conducted research dealing with diabetic complications and islet dysfunction. Their work has led to the identification of novel therapeutic targets and agents for the treatment of diabetic complications. Natarajan was also the first to demonstrate the role of epigenetics in diabetic vascular inflammation and in the metabolic memory phenomenon.

Her laboratory was also the first to demonstrate how microRNAs (small, non-coding RNAs) can cause the overproduction of collagen, which creates damage that can lead to kidney abnormalities and renal dysfunction. She used therapeutic interventions to block these microRNAs, slowing the cells’ harmful overproduction of collagen and other proteins and kidney damage.
 
 
Diagnosing type 1 diabetes sooner

Kevin Ferreri , Ph.D., has developed a new method of diagnosing type 1 diabetes. His research team detected unique markings on the DNA of insulin-producing cells. When these cells die during the progression of type 1 diabetes, the markings can be detected on DNA that circulates in the blood. This method can be used to diagnose type 1 diabetes before complications and can be used to test the effectiveness of new treatments.

To read about more of City of Hope researchers’ accomplishments, including the 1940s discovery by Rachmiel Levine, M.D., of insulin’s role in processing sugars, read our Diabetes Program History page. 
 
Overview
Beckman Research Institute of City of Hope is responsible for fundamentally expanding the world’s understanding of how biology affects diseases such as cancer, HIV/AIDS and diabetes.
 
 
Research Departments/Divisions

City of Hope is a leader in translational research - integrating basic science, clinical research and patient care.
 

Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

City of Hope’s Irell & Manella Graduate School of Biological Sciences equips students with the skills and strategies to transform the future of modern medicine.
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
 


NEWS & UPDATES
  • We’ve all heard the mantra: Cancer screening saves lives. And it does, especially with colorectal cancer. Regular colonoscopies have been proven to reduce the risk of colorectal cancer death by up to 70 percent. Screening for colorectal cancer using the even simpler fecal occult blood tests has been found to re...
  • Pick up any biotech industry report and you’re guaranteed to come across one term repeatedly – CAR-T therapy. A fierce competition is now underway to bring CAR-T treatments to market – several companies (Juno, Novartis, Kite and Cellectis, to name a few) have major stakes in the race. I’ve found the CAR-T buzz ...
  • Patients undergoing treatment at City of Hope know they will be receiving the best medical care available, that their treatment will be delivered with compassion and that their care will extend to their families. “When we treat a patient here, we treat a family,” says Jo Ann S. Namm, child life manager and spec...
  • Did you know that colorectal cancer equally affects men and women? Or that it’s the third-leading cause of cancer death in the U.S.? Most important, did you know that colorectal cancer is very treatable and highly curable if detected early? If you didn’t know these facts, it’s time to learn. M...
  • To celebrate the beginning of Lunar New  Year 2015, City of Hope honored not just a new lunar calendar, but also the diversity of the community it serves. On Jan. 21, as tens of thousands of people celebrated Lunar New Year (and the arrival of the Year of the Ram) in the streets of L.A.’s Chinatown, City of [&#...
  • The breakthroughs that have revolutionized cancer treatment, transforming cancer in many cases to a very manageable and even curable disease, started out as just ideas. “I will often tell patients there’s no therapy we’re using to help them that wasn’t derived from somebody’s idea in some laboratory, working la...
  • The prostate cancer screening debate, at least as it relates to regular assessment of prostate specific antigen levels, is far from over. The U.S. Preventive Services Task Force recommended against routine PSA screening for prostate cancer in 2012, maintaining that the routine use of the PSA blood test does mor...
  • Cancer patients should get more than medical treatment. They should get comprehensive, evidence-based care that addresses their full range of needs. That kind of patient-focused care is City of Hope’s specialty. Under the guidance of Dawn Gross, M.D., Ph.D., the new Arthur M. Coppola Family Chair in Suppo...
  • Think twice before tossing out those hormone replacement pills. Although a new Lancet study suggests that hormone replacement therapy could increase a woman’s risk of ovarian cancer, a City of Hope expert urges women to keep this news in perspective. Hormone replacement therapy is prescribed to help allev...
  • Don’t know what to take, or send, that friend of yours in the hospital? Try a paper plate — filled not with cookies or sweets, but an image of yourself. Ilana Massi, currently undergoing treatment at City of Hope for acute myeloid leukemia, can vouch for the power of such a gift. She’s surrounded herself [̷...
  • With precision medicine now a national priority, City of Hope has joined a novel research partnership designed to further understanding of cancer at the molecular level, ultimately leading to more targeted cancer treatments. The Oncology Research Information Exchange Network, or ORIEN, is the world’s larg...
  • The spinal cord is an integral part of the human body, connecting the brain to everything else. So when a tumor grows on the spine, any messages that the brain tries to send to the rest of the body are interrupted, making everyday tasks — such as walking — more difficult. This year an estimated 22,850 […]
  • Each year, thousands of patients with hematologic malignancies undergo allogeneic stem cell transplantation (that is, they receive a donor’s stem cells), offering them a chance at cure. Graft-versus-host disease is a potentially deadly complication of this therapy and occurs in approximately 25 to 60 perc...
  • Bertram Yuh, M.D., assistant clinical professor in the Division of Urology and Urologic Oncology at City of Hope, offers his perspective on the benefits of surgery for aggressive prostate cancer. For men walking out of the doctor’s office after a diagnosis of cancer, the reality can hit like a ton of bricks. Th...
  • Although many Hispanic women face a high risk of mutations in the BRCA1 and BRCA2 genes – increasing their risk of breast and ovarian cancer – screenings for these mutations can be prohibitively expensive in Mexico and other Latin American countries. As a result, too many women don’t get the information t...